PCRX - Pacira BioSciences, Inc.

QQQ $ 440.32 $ 0.07 (0.02 %)

DIA $ 388.70 $ 0.29 (0.07 %)

SPY $ 517.26 $ 0.57 (0.11 %)

TLT $ 90.79 $ 0.55 (0.61 %)

GLD $ 214.23 $ -0.99 (-0.46 %)

Previous Close

$ 26.51

Open

$ 26.87

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 26.42 - $ 27.06

52 Week Range

$ 25.33 - $ 43.81

Volume

734,457

Average Volume

Market Cap

1.38B

Beta (5Y Monthly)

$ 0.95

PE Ratio (TTM)

$ 19.63

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-02-2023	06-30-2023	10-Q
5	05-03-2023	03-31-2023	10-Q
6	02-28-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-03-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	02-28-2022	12-31-2021	10-K
11	11-03-2021	09-30-2021	10-Q
12	08-03-2021	06-30-2021	10-Q
13	05-04-2021	03-31-2021	10-Q
14	03-01-2021	12-31-2020	10-K
15	10-30-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	02-21-2020	12-31-2019	10-K
19	11-08-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-02-2019	03-31-2019	10-Q
22	02-28-2019	12-31-2018	10-K
23	11-01-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	05-03-2018	03-31-2018	10-Q
26	02-28-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-02-2017	06-30-2017	10-Q
29	05-04-2017	03-31-2017	10-Q
30	03-01-2017	12-31-2016	10-K
31	11-02-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-02-2016	03-31-2016	10-Q
34	02-25-2016	12-31-2015	10-K
35	10-27-2015	09-30-2015	10-Q
36	07-30-2015	06-30-2015	10-Q
37	04-30-2015	03-31-2015	10-Q
38	02-24-2015	12-31-2014	10-K
39	10-30-2014	09-30-2014	10-Q
40	07-31-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Maintains Buy on Pacira BioScience...
05/08/2024 10:38:30

Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and lowers the price target from $45 to...

Pacira BioSciences Reiterates Its FY24 Fin...
05/07/2024 20:34:35

Pacira BioSciences Plans $150M Share Repur...
05/07/2024 20:02:44

Pacira BioSciences Q1 2024 Adj EPS $0.62, ...
05/07/2024 20:02:02

Pacira BioSciences (NASDAQ:PCRX) reported quarterly Adj earnings of $0.62 per share which met the analyst consensus estimate. T...

A Glimpse Into The Expert Outlook On Pacir...
04/09/2024 14:00:36

Needham Reiterates Buy on Pacira BioScienc...
04/09/2024 10:16:23

Needham analyst Serge Belanger reiterates Pacira BioSciences (NASDAQ:PCRX) with a Buy and maintains $45 price target.

Pacira Biosciences Announced That FDA Has ...
03/13/2024 11:12:21

JP Morgan Assumes Pacira BioSciences at Ov...
03/07/2024 10:07:03

JP Morgan analyst Hardik Parikh assumes Pacira BioSciences (NASDAQ:PCRX) with a Overweight rating and announces Price Target...

HC Wainwright & Co. Reiterates Buy on Paci...
03/04/2024 12:02:59

HC Wainwright & Co. analyst Oren Livnat reiterates Pacira BioSciences (NASDAQ:PCRX) with a Buy and maintains $57 price t...

Navigating 4 Analyst Ratings For Pacira Bi...
03/01/2024 16:00:39

RBC Capital Maintains Outperform on Pacira...
03/01/2024 15:35:49

RBC Capital analyst Gregory Renza maintains Pacira BioSciences (NASDAQ:PCRX) with a Outperform and lowers the price target f...

Needham Reiterates Buy on Pacira BioScienc...
03/01/2024 10:30:09

Needham analyst Serge Belanger reiterates Pacira BioSciences (NASDAQ:PCRX) with a Buy and maintains $45 price target.

Pacira BioSciences Forecasts 2024 Revenue ...
02/29/2024 13:06:32

Pacira BioSciences Q4 Adjusted EPS $0.89 B...
02/29/2024 13:04:22

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0...

Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

Preview: Pacira BioSciences's Earnings
02/28/2024 15:01:26

Pacira Publishes Study Of EXPAREL As Sciat...
02/15/2024 13:42:58

– Findings demonstrate significant reduction in pain and opioid consumption through 96 hours versus active comparator – – Signi...

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
02/12/2024 17:35:25

Wedbush Reiterates Outperform on Pacira Bi...
02/08/2024 13:32:21

Wedbush analyst Andreas Argyrides reiterates Pacira BioSciences (NASDAQ:PCRX) with a Outperform and maintains $57 price target.

Pacira BioSciences Awarded Brand Pharmaceu...
02/07/2024 13:11:10

Pacira BioSciences, Inc., (NASDAQ:PCRX), the industry leader in its commitment to non-opioid pain management and regenerative h...